Evotec provides integrated gastrointestinal (GI) tract drug discovery solutions designed to advance research from early target validation through preclinical development. Leveraging human-relevant in vitro models, advanced cellular systems, and translational in vivo approaches, Evotec enables a deeper understanding of GI biology, barrier function, and disease mechanisms. With expertise spanning inflammation, microbiome interactions, and epithelial physiology, the platform supports the identification and validation of novel therapeutics, accelerating the development of effective treatments for GI disorders.